Tan Kevin's Form 4 filing
Solid Biosciences Inc. (SLDB) · filed Feb 2, 2026
- Accession no.
- 0001193125-26-034089
- Filed
- Feb 2, 2026
- Trade date
- Jan 29-Feb 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 4 derivative transactions. Open-market sales total $172.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tan KevinCIK 0001884056 | Officer (CFO & Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | Common Stock | MOption exerciseAcquired | +56,646 | –F1 | – | 102,746 | Direct | |
| Jan 31, 2026 | Common Stock | MOption exerciseAcquired | +33,075 | –F2 | – | 135,821 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −26,837 | $6.44F4 | −$172,830.28 | 108,984 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | Common Stock | MOption exerciseDisposed | −56,646 | $0.00 | $0 | 0 | Direct | |
| Jan 29, 2026 | Common Stock | AGrant or awardAcquired | +187,000 | $0.00 | $0 | 187,000 | Direct | |
| Jan 29, 2026 | Common Stock | AGrant or awardAcquired | +93,500 | $0.00 | $0 | 93,500 | Direct | |
| Jan 31, 2026 | Common Stock | MOption exerciseDisposed | −33,075 | $0.00 | $0 | 99,225 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.
- F2
Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.
Referenced by the price of 1 transaction in Table I.